This website uses cookies to ensure you get the best experience.

Magle Group and our selected partners use cookies and similar technologies (together “cookies”) that are necessary to present this website, and to ensure you get the best experience of it. If you consent to it, we will also use cookies for analytics purposes.

See our Cookie Policy to read more about the cookies we set.

You can withdraw and manage your consent at any time, by clicking “Manage cookies” at the bottom of each website page.

Select which cookies you accept

On this site, we always set cookies that are strictly necessary, meaning they are necessary for the site to function properly.

If you consent to it, we will also set other types of cookies. You can provide or withdraw your consent to the different types of cookies using the toggles below. You can change or withdraw your consent at any time, by clicking the link “Manage Cookies”, that is always available at the bottom of the site.

To learn more about what the different types of cookies do, how your data is used when they are set etc, see our Cookie Policy.

These cookies are necessary to make the site work properly, and are always set when you visit the site.

Vendors Teamtailor

These cookies collect information to help us understand how the site is being used.

Vendors Teamtailor
Skip to main content
Magle Group career site
Our organization

Production

Connect

Manufacturing

We work according to GMP and ISO standards from pre-clinical through clinical trial phases to scale up, validation and commercial manufacturing. Our Quality Control team is experienced and they make sure that the products are manufactured to the correct specifications within the Marketing Authorization (MA) or Clinical Trial Dossier (CTD). We have been successfully inspected by the FDA and our facility is regularly routinely inspected by the Swedish Medicines Agency. 

About Magle Group

Magle AB (formed in 1995 as a pure development company) acquired Chemoswed AB (formed in 1944 as a manufacturing company) in 2016 before merging the companies in 2017 to form Magle Chemoswed. In 2019, Adroit Science AB was acquired to increase the development services segment. In 2021, PharmaCept GmbH was acquired as a first step to develop a sales and marketing organization for DSM products. In 2024 Magle Group welcomed Magle Biopolymers - a CDMO part of the group focusing on Dextran technology, and Magle BioPharma - a stem cell based CDMO.

Founded in 2016
Coworkers 160+ Team members and growing

Already working at Magle Group?

Let’s recruit together and find your next colleague.

@maglegroup.com